Log In Sign Up

Unlisted Shares

IPO & Startups

Mutual Funds

PMS

Listed

Analyse

Track

  • Home
  • /
  • Sanguine Media
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Company

Listed · BSE

Sanguine Media

Film Production, Distribution & Entertainment · Founded 1995 · www.sanguinemedialtd.com · BSE 531898 · · ISIN INE617F01038

₹0.2 0.2 0%
Updated 00:00 IST
Watchlist Add to Bucket Notes Price Alert
Consolidated Standalone

My Notes

No Notes Added Yet

Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
-
Stock P/E
—
P/B
—
Current Price
₹0.2
Book Value
₹ 0
Face Value
10
52W High
—
52W Low
—
Dividend Yield
—
Edit Ratio

Sanguine Media Share Price

Live · BSE · Inception: 1995
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Sanguine Media Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 0 0 0 0 0 0 0 0 0 0
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 0 0
Operating Profit -0 -0 -0 -0 -0 0 0 0 -0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses -4 0 0 0 0 0 0 0 0 0
Profit Before Tax -4 -0 -0 -0 -0 0 0 0 -0 0
Provision for Tax -0 0 0 0 0 0 0 0 0 0
Profit After Tax -4 -0 -0 -0 -0 0 0 0 -0 0
Adjustments 0 0 -0 0 0 0 0 -0 0 0
Profit After Adjustments -4 -0 -0 -0 -0 0 0 0 -0 0
Adjusted Earnings Per Share -0.4 -0 -0 -0 -0 0 0 0 -0 0

Sanguine Media Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 8 33 6 10 0 0 0 0 0 0 0 0
Other Income 0 0 0 0 0 -0 0 0 0 0 0 0
Total Income 8 33 6 10 0 -0 0 0 0 0 0 0
Total Expenditure 7 32 6 10 0 0 2 0 0 0 0 0
Operating Profit 1 1 0 0 -0 -0 -2 -0 -0 -0 -0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -4 0 0
Profit Before Tax 0 0 0 0 -0 -0 -2 -0 -0 -4 -0 0
Provision for Tax 0 0 0 0 0 0 0 0 -2 0 0 0
Profit After Tax 0 0 0 0 -0 -0 -2 -0 2 -4 -0 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 -0 -0 -2 -0 2 -4 -0 0
Adjusted Earnings Per Share 0 0.2 0 0 -0 -0 -0.2 -0 0.2 -0.4 -0 0

Sanguine Media Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 125 125 126 126 126 126 124 124 126 122 121
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 3 3 3 3 3 3 3 3 0 0 0
Total Current Liabilities 20 57 33 30 30 30 30 30 22 12 2
Total Liabilities 147 185 161 159 158 158 156 156 148 133 123
Fixed Assets 13 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 105 102 85 77 81 81 81 81 73 63 63
Total Current Assets 27 81 74 79 75 75 75 75 74 70 60
Total Assets 147 185 161 159 158 158 156 156 148 133 123

Sanguine Media Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities 2 -3 -18 4 -0 -0 -2 -0 -8 -0 -0
Cash Flow from Investing Activities -2 3 6 9 0 0 2 0 0 0 0
Cash Flow from Financing Activities -0 -0 12 -13 -0 0 0 0 8 0 0
Net Cash Inflow / Outflow -0 0 0 -0 -0 0 0 -0 0 0 -0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 0 0

Sanguine Media Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.02 0.2 0.02 0.02 -0 -0.02 -0.17 -0 0.18 -0.36 -0.01
CEPS(Rs) 0.07 0.61 0.02 0.02 -0 -0.02 -0.17 -0 0.18 -0.36 -0.01
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 10.8 108.24 10.84 10.86 10.86 10.84 10.83 10.83 11.01 10.65 10.64
Core EBITDA Margin(%) 7.51 1.61 0.02 0.97 -15.08 0 0 0 0 -209.58 0
EBIT Margin(%) 3.04 0.98 5.2 2.57 -5.17 0 0 0 0 -4317.47 0
Pre Tax Margin(%) 3.01 0.97 5.2 2.2 -5.18 0 0 0 0 -4317.47 0
PAT Margin (%) 2.61 0.69 4.18 1.7 -5.18 0 0 0 0 -4317.47 0
Cash Profit Margin (%) 10.82 2.13 4.18 1.7 -5.11 0 0 0 0 -4317.47 0
ROA(%) 0.14 0.14 0.14 0.11 -0.01 -0.14 -1.23 -0 1.32 -2.92 -0.12
ROE(%) 0.16 0.18 0.2 0.14 -0.02 -0.18 -1.56 -0.01 1.61 -3.32 -0.13
ROCE(%) 0.17 0.24 0.22 0.19 -0.02 -0.17 -1.42 -0.01 -0.01 -3.16 -0.13
Receivable days 890.33 266.38 1588.74 682.97 0 0 0 0 0 0 0
Inventory Days 191.01 116.39 0 603.97 0 0 0 0 0 0 0
Payable days 300.58 299.13 2163.93 735.43 0 0 0 0 0 0 0
PER(x) 33.33 5.03 51.4 35.53 0 0 0 0 0 0 0
Price/Book(x) 0.06 0.01 0.1 0.05 0.02 0 0 0 0 0 0
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 2.4 0.39 4.05 1.73 33.81 0 0 0 0 1213.7 0
EV/Core EBITDA(x) 21.36 16.06 77.76 67.09 -663.63 -558.37 -65.29 0 -6936.03 -1134.86 -721.56
Net Sales Growth(%) -44.56 329.04 -82.17 74.86 -96.03 -100 0 0 0 0 -100
EBIT Growth(%) 122.38 38.16 -5.32 -13.51 -107.97 -974.8 -754.06 99.65 -166.18 0 96.1
PAT Growth(%) 172.07 13.68 7.57 -28.91 -112.1 -972.2 -754.06 99.65 0 -304.32 96.1
EPS Growth(%) 181.25 1005.34 -89.24 -28.97 -111.84 -994.44 -755.84 99.64 0 -304.38 96.11
Debt/Equity(x) 0.09 0.1 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.01 0.01
Current Ratio(x) 1.37 1.41 2.23 2.62 2.53 2.54 2.53 2.53 3.38 5.94 34.46
Quick Ratio(x) 1.17 1.12 2.23 2.06 1.96 1.96 1.96 1.96 2.61 4.87 27.23
Interest Cover(x) 80.99 74.8 0 6.83 -413.37 0 0 0 0 0 0
Total Debt/Mcap(x) 1.69 1.03 0.92 1.87 5.33 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR — — — -100%
Operating Profit CAGR — — — -100%
PAT CAGR — — — —
Share Price CAGR — — 0% -17%
ROE Average 0% -1% -1% 0%
ROCE Average 0% -1% -1% 0%

Sanguine Media Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 0 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 100 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 0000000000
FII 0000000000
DII 0000000000
Public 100100100100100100100100100100
Others 0000000000
Total 100100100100100100100100100100

Sanguine Media Peer Comparison

Film Production, Distribution & Entertainment Edit Columns
Open Film Production, Distribution & Entertainment industry page ›

Sanguine Media Quarterly Price

10-year quarterly close · BSE
Quarterly Monthly
Show Value Show %

News & Updates

See more…

Sanguine Media Pros & Cons

Auto-generated · Sharescart Insights

Pros

Cons

  • Promoter holding is low: 0%.
  • Company has a low return on equity of -1% over the last 3 years.

* The pros and cons are machine generated.

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Explore More

You may also know about

Unlisted Shares

Private & pre-listed companies

Pre-IPO Shares

Invest before the listing

ESOP Shares

Employee stock options

Delisted Shares

Companies no longer on exchanges
whatsapp

Error!

View quotes